Precision for Medicine
Kurt PreugschatDirector
Kurt Preugschat is a seasoned biostatistician with over 14 years of experience in pharmaceutical and biotechnology drug development. He brings deep expertise across the full clinical trial lifecycle, from early-phase development through regulatory submission and post-marketing activities. His work spans Phase I–IV clinical trials, with a strong focus on delivering high-quality, scientifically rigorous statistical strategies that support informed decision-making and successful regulatory outcomes.
Insights from Kurt Preugschat
Research & Development | White Paper
Advancing Radiopharmaceuticals From Regulatory Approval to Global Access